Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
Stephen Harnicar, Sherry Mathew Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA Abstract: Nowhere has targeted therapy been more successful in the hematologic malignancy arena than chronic myelogenous leukemia (CML). By
Harnicar S, Mathew S
core
Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
The publication provides an up-to-date review of the significance of cytogenetic abnormalities in chronic myelogenous leukemia (CML) and the development of a promising agent with specific molecular target against tyrosine kinase, product of the BCR-ABL ...
Ladislav Chrobák, Jaroslava Voglová
doaj +1 more source
The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines
We evaluated the effect of the human immunodeficiency virus (HIV) protease inhibitor saquinavir on the imatinib-sensitive and imatinib-resistant chronic myelogenous leukemia cell lines.
F Timeus +6 more
doaj
Curcumin induces selective packaging of miR-21 in exosomes released by Chronic Myelogenous Leukemia ...
Marzia Pucci +6 more
core
Targeting Chronic Myelogenous Leukemia with Imatinib and Glycyrrhizic Acid Combination Therapy
Examining the efficacy of an imatinib and glycyrrhizic acid combination treatment on chronic myelogenous leukemia cell lines.
Adir Mohaban, Olga N. Uchakina
core
Ponatinib: An oral tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome -- positive acute lymphoblastic leukemia [PDF]
Ponatinib (Iclusig; Ariad Pharmaceuticals) is an oral tyrosine kinase inhibitor (TKI) that was approved by FDA on December 14, 2012, for the treatment of adult patients with chronic-phase, accelerated-phase, or blast-phase chronic myelogenous leukemia ...
Feret, Brett
core +1 more source
Chronic myelogenous leukemia terminating in acute megakaryoblastic leukemia. Case report
A case of chronic myelogenous leukemia (CML) terminating in acute megakaryoblastic leukemia (AMKL) is here presented. Megakaryoblasts were identified by the presence of platelet peroxidase in the bone marrow as well as in pleural effusion and ascites ...
Bai, M. +5 more
core
"Transformation of chronic myelogenous leukemia to Multiple Myeloma: A case report " [PDF]
Chronic myelogenous leukemia (CML) is a stem cell disorder sometimes associated with lymphoproliferative disorders. CML may precede a lymphoproliferative disorder.
"Ghavamzadeh A +5 more
doaj
Applications of Microarray Technology to Acute Myelogenous Leukemia
Microarray technology is a powerful tool, which has been applied to further the understanding of gene expression changes in disease. Array technology has been applied to the diagnosis and prognosis of Acute Myelogenous Leukemia (AML).
Mahadeo A. Sukhai +4 more
core
Chronic Myelogenous Leukemia Guidelines
Chronic myelogenous leukemia (CML) accounts for 15% of adult leukemias. In 2007, an estimated 4500 cases will be diagnosed and 900 patients will die of the disease.
_ _
core +1 more source

